Location: Boston, MA
CIK: 0001990717 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 10, 2026
Total Value: $498M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RAPP | RAPPORT THERAPEUTICS, INC. | 6,280,525 (-12.0%) | $262M (+17.2%) | 52.5% | $22.16 | — | COM | 75383L102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SEPN | SEPTERNA, INC. | 6,215,591 | $208M | 41.8% | $23.65 | — | COM | 81734D104 |
| MAZE | MAZE THERAPEUTICS, INC. | 950,800 | $28.37M | 5.7% | $12.04 | — | COM | 578784100 |